<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgments</title>
 <p>The collaborators thank all the study participants and the members of the trial DSMBs. We would also like to thank Alan D. Barrett, Eunice Kamaara, the Scientific Committee of the YEFE trial, the WHO, Joachim Hombach, Annelies Wilder-Smith, the teams at the National Institute for Biological Standards and Control (NIBSC) and the four vaccine manufacturers; Institut Pasteur de Dakar, Sanofi Pasteur SA, Bio-Manguinhos/Fiocruz and Federal State Unitary Enterprise of Chumakov Institut of Poliomyelitis and Viral Encephalitidis for sharing their resources and support for the trials.</p>
 <p>This manuscript is published with permission from the Director of KEMRI.</p>
 <p>This work is a collaboration between investigators at the University of Oxford and the KEMRI-Wellcome Trust Research Programme, Kenya; Epicentre, Paris and its research base in Mbarara, Uganda; Uganda Virus Research Institute, Entebbe; and the Institut Pasteur de Dakar in Senegal.</p>
 <p>The YEFE and NIFTY vaccine trials teams are made up of: Aitana Juan, Rebecca Grais, Marie Francoise Scherrer, Kyra Grant, Derek Cummings, Alexandra Ascorra, Céline Langendorf, Deborah Nanjebe, Mateus Kambale, Caroline Nerima, Patrick Kazooba, Dan Nyehangane, Alaleh Abadpour, Rinah Arinaitwe, Justus Ainomugisha, Miria Nyangome, Diana Birungi, Sheila Yvonne Mbabazi, Allen Tukamuhebwa, Joshua Musiimenta, Colman Tayebwa, Sarah Namwanje, Derrick Kasosi, Maria Louise Namulwana, Collins Agababyona, Shivan Atuhaire, Pedison Ayebazibwe, Susan Logoose, Florence Abok, Grace Atuk, Sheila Abaasabyoona, Derick Hope, Moreen Kembabazi and Juliet Mwanga at Epicentre, Paris and Mbarara, Uganda; Derick Kimathi, George Warimwe, Philip Bejon, Henry Karanja, Mainga Hamaluba, Neema Mturi, Marianne Munene, Jackline Wafula, Naomi Kamau, Donwilliams Omuoyo, John Gitonga, Kenneth Kiogora, Felix Moki, Stanley Cheruiyot, Clinton Mwatata, Stephen Mwangala, Everlyne Nzula, Jane Mwendwa, Esther Kivaya, Hellen Mnjalla, Irene Njau, Eduard Sanders, Debbie Riako, Jimmy Shangala, Andrew Guantai, Fidelis Achami, Josephine Bendera, Rufus Ng’ang’a, James Mwavita, Anna Kambu, Evans Gichuru, Caroline Ngetsa, Anne Githinji, Oscar Chirro, Moses Mosobo and Jennifer Musyoki at the KEMRI-Wellcome Trust Research Programme in Kilifi Kenya; Gamou Fall, Moussa Dia, Ndeye Sakha, Antoine Diatta, Myriam Grubo and Amadou Sall at the Institut Pasteur de Dakar; and John Kayiwa, Julius Lutwama and Pontiano Kaleebu at the Uganda Virus Research Unit.</p>
</ack>
